Biologic Agents for the Treatment of Juvenile Rheumatoid Arthritis

This publication has 51 references indexed in Scilit:

• New Indications for Treatment of Chronic Inflammation by TNF-α Blockade
  The Lancet Healthy Longevity, 2003
• Tumor necrosis factor antagonist therapy and lymphoma development: Twenty‐six cases reported to the Food and Drug Administration
  Arthritis & Rheumatism, 2002
• Long‐term safety and maintenance of clinical improvement following treatment with anakinra (recombinant human interleukin‐1 receptor antagonist) in patients with rheumatoid arthritis: Extension phase of a randomized, double‐blind, placebo‐controlled trial
  Arthritis & Rheumatism, 2002
• Tuberculosis Associated with Infliximab, a Tumor Necrosis Factor α–Neutralizing Agent
  New England Journal of Medicine, 2001
• Anti-interleukin 6 receptor antibody treatment in rheumatic disease
  Annals of the Rheumatic Diseases, 2000
• TNF? and the TNF receptor superfamily: Structure-function relationship(s)
  Microscopy Research and Technique, 2000
• Immunological evaluation of cytokine and anticytokine immunotherapy in vivo: what have we learnt?
  Annals of the Rheumatic Diseases, 1999
• The Pathophysiology of Tumor Necrosis Factors
  Annual Review of Immunology, 1992
• Detection of tumor necrosis factor α but not tumor necrosis factor β in rheumatoid arthritis synovial fluid and serum
  Arthritis & Rheumatism, 1988
• Tumour necrosis factor α stimulates resorption and inhibits synthesis of proteoglycan in cartilage
  Nature, 1986